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Study unravels link between surgery, diabetes remission
By Krishna Ramanujan
Researchers and doctors have known for years that patients who receive bariatric surgeries –
gut surgeries with the goal of weight loss – often experience remission of Type 2 diabetes.
Clinicians ˇnd that diabetes remission begins within days after such surgeries, well before
weight loss occurs.
No one has fully understood the mechanisms behind these eVects, but a recent Cornell-led
study published in the journal Gut provides clues to the mystery. The ˇndings open doors for
novel drug treatments to treat Type 2 diabetes.
The study, which was done with mice, reveals that bariatric surgeries increase bile acid
concentrations, and in concert with a bile acid receptor called TGR5, play critical roles in
balancing glucose levels in the body, which help treat diabetes. Signaling from TGR5 was found
to regulate several metabolic outcomes, including: glucose homeostasis, in싪�ammation and liver
insulin signaling.
But the researchers caution that bariatric surgery may not be the answer for all patients
suVering from Type 2 diabetes.
“In the United States, bariatric surgeries are primarily allowed for obesity treatment, generally
requiring a BMI over 40 or a BMI over 35 with signiˇcant obesity-related co-morbidities,” though
some clinicians argue for expanding the use of these surgeries for treatment of diabetes, said
Bethany Cummings, assistant professor of biomedical sciences in Cornell’s College of Veterinary
Medicine and the paper’s senior author. Anne McGavigan, a postdoctoral researcher in
Cummings’ lab, is the paper’s ˇrst author.
“Our goal is to study these surgeries in order to identify novel therapeutic targets, because
surgery is not without risks and a drug is much easier to widely distribute amongst patients,”
said Cummings. The study points to TGR5 as a possible target for diabetes treatment, and more
research on this bile acid receptor may also lead to treatments that exploit TGR5 and bile acid
links, she added.
In the study, the researchers conducted a sham surgery or a common bariatric surgery called a
vertical sleeve gastrectomy (VSG) in high-fat-fed normal lab mice, and in specially engineered
mice without TGR5 receptors.
In a VSG, surgeons cut along the curve of the stomach and remove roughly 70 percent, leaving a
tubular organ. The sham surgery created sutures in the stomach but didn’t remove any stomach
tissue, to test if surgery itself contributed to eVects. A third group of normal mice were given a
sham surgery but were also placed on a restricted diet to control for weight loss.
Cummings and colleagues found that after the VSG, circulating concentrations of bile acids in
the normal mice greatly increased – for reasons not yet understood. Furthermore, VSG in the
normal mice favored beneˇcial bile acids. Bile acids come in diVerent forms, a less beneˇcial
hydrophobic (water repelling) form and a healthier hydrophilic (water attracting) form. The
experiments revealed that signaling from TGR5 speciˇcally contributed to the increase in
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hydrophilic bile acids, which in turn helped balance and regulate glucose in these mice after
VSG surgery.
While weight loss does contribute to Type 2 diabetes remission, “the thing we are excited about
is it’s not just the weight loss,” said Cummings. “Coming up with methodologies other than
weight loss to treat diabetes is critical.”
Future work will further explore TGR5 function, as there appears to be a lot that we still don’t
know about the function of this receptor, Cummings said.
“Doing these surgeries in tiny mice is no small feat, but it helps move our understanding of how
bariatric surgery causes Type 2 diabetes remission forward,” she added.
Co-authors include researchers from the University of California, Davis, and Lilly Research
Labs.
The study was funded by Eli Lilly and Co., the National Institutes of Health and Cornell
University.
